OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type: 
Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.